alexa Celiac disease | United-states | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

Celiac Disease

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Celiac disease

    Celiac disease is an immune reaction to eating gluten, a protein found in wheat, barley and rye. If you have celiac disease, eating gluten triggers an immune response in your small intestine. Over time, this reaction produces inflammation that damages the small intestine's lining and prevents absorption of some nutrients (malabsorption).

  • Celiac disease

    In addition to digestive problems, other signs and symptoms of celiac disease include: Anemia, usually resulting from iron deficiency Loss of bone density (osteoporosis) or softening of bone (osteomalacia) Itchy, blistery skin rash (dermatitis herpetiformis) Damage to dental enamel Headaches and fatigue Nervous system injury, including numbness and tingling in the feet and hands, and possible problems with balance Joint pain Reduced functioning of the spleen (hyposplenism) Acid reflux and heartburn

  • Celiac disease

    1. Confirmed diagnosis. 2. Treatment begins. Treatment is a prescription - lifelong elimination of "gluten". You are going to be healthier. No surgery is required. No medication is required. The only known treatment for celiac disease to date is a gluten-free diet.

  • Celiac disease

    CD was found in 35 participants, 29 of whom were unaware of their diagnosis. Median age was 45 years (interquartile range, 23-66 years); 20 were women and 29 were non-Hispanic white. The prevalence of CD in the United States was 0.71% (95% confidence interval (CI), 0.58-0.86%), with 1.01% (95% CI, 0.78-1.31%) among non-Hispanic whites. In all, 55 participants reported following a GFD, which corresponded to a prevalence of 0.63% (95% CI, 0.36-1.07%).

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

adwords